IL-4 inhibition

interleukin-4 pathway inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-4 inhibition, covering 2023-08-01 to 2023-08-01. Get the full timeline:

Most recent: Clinical Trial Update: PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer [Phase 2]